Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IPSRT +/- Quetiapine for Bipolar II Depression
NCT01133821Phase 4Completed
- Start
- Aug 2010
- Primary completion
- Oct 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in Bipolar II disorder (BP-II) comparing IPSRT + Placebo with IPSRT + Quetiapine (2 arms). Primary endpoint: Remission at 20 weeks. Started Aug 2010; status: completed.
02
Drugs
quetiapine
03
Conditions
Bipolar II disorder (BP-II)
Beyond the preview
Go deeper on NCT01133821.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01133821.